BRCA2 and ovarian serous adenocarcinoma: BRCA1 and BRCA2 alterations are frequently observed in familial and sporadic serous ovarian cancer7, 54 with approximately 15% of serous ovarian cancer patients exhibiting BRCA germline mutations.55